Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome

Fam Cancer. 2023 Jul;22(3):319-321. doi: 10.1007/s10689-022-00326-9. Epub 2023 Jan 11.

Authors

Ixtaccihuatl H Obregón¹, Kelvin C de Andrade¹, Renee C Bremer¹, Payal P Khincha¹, Sharon A Savage²

Affiliations

¹ Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 6E456, Bethesda, MD, 20892-6772, USA.
² Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Room 6E456, Bethesda, MD, 20892-6772, USA. savagesh@mail.nih.gov.

No abstract available

Keywords: Autoimmune disorder; Li-Fraumeni Syndrome; TP53.

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Intramural

MeSH terms

Autoimmune Diseases* / complications
Autoimmune Diseases* / epidemiology
Genes, p53
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Li-Fraumeni Syndrome* / epidemiology
Li-Fraumeni Syndrome* / genetics
Pilot Projects
Prevalence
Tumor Suppressor Protein p53 / genetics

Substances

Tumor Suppressor Protein p53

Grants and funding